Cost-effectiveness of Ritalin™ versus Adderall™ for first-line treatment of attention deficit/hyperactivity disorder (ADHD) in children

被引：0
|
作者：
Narayan, S [1 ]
Hay, JW [1 ]
机构：
[1] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62235-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [21] Actual treatment of attention deficit hyperactivity disorder (ADHD)
    Palomino, Ma. D.
    Perez Guerrero, C.
    Martin-Calero, Ma. J.
    PHARMACEUTICAL CARE ESPANA, 2013, 15 (04): : 147 - 156
  • [22] Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naive children and adolescents with attention deficit/hyperactivity disorder
    Montoya, Alonso
    Hervas, Amaia
    Cardo, Esther
    Artigas, Josep
    Mardomingo, Maria J.
    Alda, Jose A.
    Gastaminza, Xavier
    Garcia-Polavieja, Maria J.
    Gilaberte, Inmaculada
    Escobar, Rodrigo
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (11) : 2745 - 2754
  • [23] Memory Updating Deficit in Attention Deficit Hyperactivity Disorder (ADHD) Children
    Zhang, Wei
    Fan, Li
    Jiang, Ye-Ping
    PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON MEDICINE AND BIOPHARMACEUTICALS, 2016, : 3 - 11
  • [24] A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
    King, S.
    Griffin, S.
    Hodges, Z.
    Weatherly, H.
    Asseburg, C.
    Richardson, G.
    Golder, S.
    Taylor, E.
    Drummond, M.
    Riemsma, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (23) : 1 - +
  • [25] EFFECTIVENESS OF EEG BIOFEEDBACK ON COGNITIVE SHIFT IN CHILDREN WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Bakhtadze, S.
    Janelidze, M.
    Khachapuridze, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 153 - 153
  • [26] Treatment for attention deficit hyperactivity disorder (ADHD) and the risk of poisoning in children and adolescents
    Gao, Le
    Man, Kenneth K.
    Chan, Esther W.
    Chui, Celine
    Li, Xue
    Coghill, David
    Hon, Kam Lun
    Tse, Man Li
    Lum, Terry
    Wong, Kirstie H.
    Ip, Patrick
    Wong, Ian C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 372 - 372
  • [27] Atomoxetine:: a new treatment for attention deficit/hyperactivity disorder (ADHD) in children and adolescents
    Purper-Ouakil, D
    Fourneret, P
    Wohl, M
    Rénéric, JP
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (03): : 337 - 348
  • [28] THE COST EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN ADULT PATIENTS
    Schlander, M.
    Philipsen, A.
    Schwarz, O.
    VALUE IN HEALTH, 2011, 14 (07) : A403 - A403
  • [29] The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents
    Froelich, Jan
    Banaschewski, Tobias
    Spanagel, Rainer
    Doepfner, Manfred
    Lehmkuhl, Gerd
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2012, 40 (05): : 287 - 300
  • [30] Reassessing the efficacy of Adderall after prolonged treatment for attention deficit hyperactivity disorder
    Ahmann, PA
    Campbell, LR
    Theye, FW
    Berg, RM
    Linquist, AJ
    ANNALS OF NEUROLOGY, 2002, 52 (03) : S159 - S159
12345